Cyber Monday saleUp to 70% OFF
Guided Therapeutics, Inc.Guided Therapeutics, Inc.Guided Therapeutics, Inc.

Guided Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

GTHP chart


Full chart

Key stats


Market capitalization
‪11.59 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0424 USD
Net income (FY)
‪−3.49 M‬ USD
Revenue (FY)
‪98.00 K‬ USD
Shares float
‪31.05 M‬
Beta (1Y)
3.31

Employees


Employees (FY)
6
Change (1Y)
−2 −25.00%
Revenue / Employee (1Y)
‪16.33 K‬ USD
Net income / Employee (1Y)
‪−581.50 K‬ USD

About Guided Therapeutics, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Mark L. Faupel
Website
guidedinc.com
Headquarters
Norcross
Founded
1992
FIGI
BBG000BQP3M1
Guided Therapeutics, Inc. is a medical technology company, which engages in developing medical devices. It also focuses on the selling and marketing of its LuViva advanced cervical scan non-invasive cervical cancer detection device. The company was founded by Shabbir Bakir Bambot and Mark L. Faupel in 1992 and is headquartered in Norcross, GA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

GTHP news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GTHP is 0.1900 USD — it has increased by 18.75% in the past 24 hours. Watch Guided Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Guided Therapeutics, Inc. stocks are traded under the ticker GTHP.
GTHP stock has risen by 2.70% compared to the previous week, the month change is a 25.00% rise, over the last year Guided Therapeutics, Inc. has showed a 11.76% increase.
GTHP reached its all-time high on Apr 6, 2016 with the price of 103,550.3580 USD, and its all-time low was 0.0206 USD and was reached on Mar 29, 2019. View more price dynamics on GTHP chart.
See other stocks reaching their highest and lowest prices.
GTHP stock is 15.79% volatile and has beta coefficient of 3.31. Track Guided Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Guided Therapeutics, Inc. there?
Today Guided Therapeutics, Inc. has the market capitalization of ‪11.59 M‬, it has increased by 0.70% over the last week.
Yes, you can track Guided Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
GTHP net income for the last quarter is ‪−654.00 K‬ USD, while the quarter before that showed ‪−709.00 K‬ USD of net income which accounts for 7.76% change. Track more Guided Therapeutics, Inc. financial stats to get the full picture.
No, GTHP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 30, 2024, the company has 6.00 employees. See our rating of the largest employees — is Guided Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Guided Therapeutics, Inc. EBITDA is ‪−1.97 M‬ USD, and current EBITDA margin is ‪−3.44 K‬%. See more stats in Guided Therapeutics, Inc. financial statements.
Like other stocks, GTHP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Guided Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Guided Therapeutics, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Guided Therapeutics, Inc. stock shows the sell signal. See more of Guided Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.